Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: vasotec / niacin attending: chief complaint: fatigue major surgical or invasive procedure: s/p mvr(tissue) history of present illness: 83y/o male with mvp s/p mi with stenting to lad, lm and lcx. ef 10%. patient deferred surgery until he had further strength and conditioning prior to valve repair. cardiac cath on showed patent stents ef 25-30%, 3+mr,2+ar, pul htn, rca 100% occluded. past medical history: myxomatous mitral valve prolapse with mild-moderate mr and early lv volume overload hypertension gout peripheral vascular disease hypercholesterolemia aortic stenosis with moderate aortic insufficiency chronotropic incompetence, even with 2 mg atropine on kidney stone ulcer rbbb oa cva basal cell ca left cheek social history: retired orthodondist, quit smoking about 10 years ago. used to smoke 1-2 packs/day for >20 years. about 1 glass of wine daily. family history: noncontributory physical exam: 83y/o male nad heent anicteric, eomi, o/p clear, -jvd chest ctab, rrr median sternotomy c/d/i no erythema or discharge abdomen s/nt/nd/bs+, r reducible inguinal hernia ext bilateral trace edema, no cyanosis neuro nonfocal pertinent results: chest (portable ap) 12:18 pm chest (portable ap) reason: ct removal medical condition: 83 year old man with mvp/mr s/p mvr reason for this examination: ct removal portable chest, dated comparison: . indication: chest tube removal. the patient is status post mitral valve replacement. there has been interval removal of various lines and tubes including a left-sided chest tube, with no evidence of pneumothorax. cardiac and mediastinal contours are stable. there is persistent increased opacity in left retrocardiac region as well as a left pleural effusion. there is an apparently new right pleural effusion, partially layering on this semi-upright study. dr. 05:30am blood wbc-10.4 rbc-3.58* hgb-10.8* hct-31.8* mcv-89 mch-30.2 mchc-34.0 rdw-16.7* plt ct-161 05:30am blood plt ct-161 04:06am blood fibrino-211 05:30am blood glucose-114* urean-29* creat-1.5* na-139 k-4.2 cl-104 hco3-28 angap-11 04:06am blood alt-8 ast-35 ld(ldh)-251* alkphos-56 amylase-64 totbili-0.6 05:30am blood calcium-8.5 phos-2.6*# mg-2.1 02:55pm blood %hba1c-5.6 -done -done procedure date: indications for catheterization: cad, ai, mr, tr final diagnosis: 1. three vessel coronary artery disease with patent stents in lad and lcx 2. moderate-severe mr 3. moderate ai 4. elevation of left sided filling pressures comments: 1. selective coronary angiography in this co dominant patient revealed patent stents. the lmca had a 20% origin occlusion. the lad and lcx had patent stents and provided left to right collaterals. the rca was a small vessel and was occluded after mid segment. 2. resting hemodynamics revealed elevation of left sided filling pressures with pcwp and lvedp of 25-28mmhg. there were v waves on the wedge tracing to 45mmhg consistent with severe mr. there was moderate pulmonary hypertension with mean pa pressure of 38mmhg. cardiac output was not formally calculated but mean pa sat was 66% 3. lv gram revealed global hypokinesis with ef 25-30% and 3plus mr. 4. aortogram revealed 2plus ai technical factors: total time (lidocaine to test complete) = 41 minutes. arterial time = 29 minutes. fluoro time = 6 minutes. contrast: non-ionic low osmolar (isovue, optiray...), vol 146 ml, indications - renal premedications: asa 325 mg p.o. anesthesia: 1% lidocaine subq. anticoagulation: other medication: fentanyl 25mcg iv sodium bicarbonate 87cc/hr versed .5mg iv cardiac cath supplies used: 200cc mallincrodt, optiray 200cc 100cc mallincrodt, optiray 100cc echocardiography report , tte (complete) done at 1:30:00 pm final referring physician information , , ste 2a , status: outpatient age (years): 83 m hgt (in): 67 bp (mm hg): / wgt (lb): 160 hr (bpm): 71 bsa (m2): 1.84 m2 indication: mvp icd-9 codes: 424.0 test information date/time: at 13:30 interpret md: , md test type: tte (complete) son: doppler: full doppler and color doppler test location: echo lab contrast: none tech quality: adequate tape #: 2005c031-1:00 machine: a-55-8 echocardiographic measurements results measurements normal range left atrium - long axis dimension: *5.4 cm <= 4.0 cm left atrium - four chamber length: *6.1 cm <= 5.2 cm right atrium - four chamber length: *6.1 cm <= 5.0 cm left ventricle - septal wall thickness: 1.1 cm 0.6 - 1.1 cm left ventricle - inferolateral thickness: 1.0 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: *6.6 cm <= 5.6 cm left ventricle - ejection fraction: 45% to 50% >= 55% aorta - valve level: 2.6 cm <= 3.6 cm aortic valve - peak velocity: 1.9 m/sec <= 2.0 m/sec aortic valve - mean gradient: 10 mm hg aortic valve - valve area: *1.7 cm2 >= 3.0 cm2 tr gradient (+ ra = pasp): *68 mm hg <= 25 mm hg findings left atrium: moderate la enlargement. right atrium/interatrial septum: moderately dilated ra. left ventricle: normal lv wall thickness. moderately dilated lv cavity. mildly depressed lvef. right ventricle: dilated rv cavity. normal rv systolic function. aorta: normal aortic root diameter. aortic valve: no as. mild (1+) ar. mitral valve: mildly thickened mitral valve leaflets. moderate/severe mvp. mild thickening of mitral valve chordae. moderate (2+) mr. tricuspid valve: mildly thickened tricuspid valve leaflets. moderate tr. severe pa systolic hypertension. pulmonic valve/pulmonary artery: thickened pulmonic valve leaflets. physiologic (normal) pr. pericardium: no pericardial effusion. conclusions the left atrium is moderately dilated. the right atrium is moderately dilated. left ventricular wall thicknesses are normal. the left ventricular cavity is moderately dilated. overall left ventricular systolic function is mildly depressed. resting regional wall motion abnormalities include thinned and akinetic inferior segments and hypokinetic inferolateral segments. the right ventricular cavity is dilated. right ventricular systolic function is normal. there is no aortic valve stenosis. mild (1+) aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. there is moderate/severe mitral valve prolapse. moderate (2+) mitral regurgitation is seen. the tricuspid valve leaflets are mildly thickened. moderate tricuspid regurgitation is seen. there is severe pulmonary artery systolic hypertension. the pulmonic valve leaflets are thickened. there is no pericardial effusion. electronically signed by , md, interpreting physician brief hospital course: this 83wm was admitted on and underwent mvr with #29 perimount thermafix pericardial valve. he tolerated the procedure well and was transferred to the csru in stable condition on milrinone, epinephrine, and neo. the cross clamp time was 39 minutes and total bypass time was 57 minutes. his drips were weaned overnight and he was extubated on pod#1. he was transferred to the floor on pod#2 and continued to progress well. his chest tubes were d/c'd on pod#2 and his epicardial pacing wires were d/c'd on pod#4. he went into af at a controlled rate on pod#4 and converted with 1 dose of amiodorone. he remained in sr and was dishcarged to rehab on pod#6 in stable condition. medications on admission: zocor 20 mg po daily asa 325 mg po daily plavix 75 mg po daily losartan 25 mg po daily lasix 20 mg po 3x/wk lopressor 50 mg po daily folic acid 1 mg po daily colace 100 mg po bid discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 2. furosemide 20 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 7 days. 3. potassium chloride 10 meq capsule, sustained release sig: two (2) capsule, sustained release po q12h (every 12 hours) for 7 days. 4. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 5. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. 6. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). 7. zocor 40 mg tablet sig: one (1) tablet po once a day. 8. amiodarone 400 mg tablet sig: one (1) tablet po once a day for 7 days: after dose complete, decrease dose to 200 mg po daily. tablet(s) discharge disposition: extended care facility: for the aged - discharge diagnosis: coronary artery disease mitral regurgitation atrial fibrillation ^chol. htn gout nephrolithiasis s/p pulmonary emboli s/p ivc filter anemia discharge condition: good discharge instructions: follow medications on discharge instructions. do not drive for 4 weeks. do not lift more than 10 lbs. for 3 months. you should shower daily, let water flow over wounds, pat dry with a towel. do not use lotions, powders, or creams on wounds. followup instructions: make an appointment with dr. for 1-2 weeks. make an appointment with dr. for 4 weeks. procedure: extracorporeal circulation auxiliary to open heart surgery open and other replacement of mitral valve with tissue graft diagnoses: coronary atherosclerosis of native coronary artery gout, unspecified atrial fibrillation other chronic pulmonary heart diseases atrial flutter paroxysmal ventricular tachycardia multiple involvement of mitral and aortic valves personal history of malignant melanoma of skin benign neoplasm of heart 

Answer: The patient is high likely exposed to